For instance, p110α is the primary PI3K kinase that activates PI3K signaling downstream of insulin receptors [92,94], which is why inhibitors targeting p110α induce hyperglycemia in patients [97]. This evidence concerns the gene PIK3CG and Hyperglycemia.